Analysts Anticipate IWN To Hit $175 Tuesday, August 8, 10:49 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Inozyme Pharma Becomes Oversold (INZY) Wednesday, September 6, 11:58 AM ET, by Market News Video Staff Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Top Buys by Directors: Hopfner's $2.4M Bet on INZY
By Market News Video Staff, Wednesday, June 21, 5:01 PM ET
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $2.4M invested across 2 purchases by Robert Lorne Hopfner, Director at Inozyme Pharma Inc (NASDAQ:INZY).
Hopfner bets big on INZY:
Purchased
Insider
Title
Shares
Price/Share
Value
03/28/2023
Robert Lorne Hopfner
Director
207,840
$4.05
$841,063.32
03/29/2023
Robert Lorne Hopfner
Director
344,592
$4.54
$1,563,724.04
Hopfner's average cost works out to $4.35/share. Shares of Inozyme Pharma Inc were changing hands at $5.83 at last check, trading up about 1.9% on Wednesday. The chart below shows the one year performance of INZY shares, versus its 200 day moving average:
Looking at the chart above, INZY's low point in its 52 week range is $0.991 per share, with $7.24 as the 52 week high point — that compares with a last trade of $5.83.
This Article's Word Cloud:BuysCompanyDaysDirectorDirectorsDollarsHopfnerINZYInozymeInsiderJoinLookingLorneOfferPharmaPresumablyPricePurchasedRobertSevenShareSharesSpecialStartTitleValueValueForumWednesdayaboutaboveacrossaveragebelowbetsbuyschartcompanydirectorslastmakemaybemdashpointsharestocktakethattheyweekwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Play Video:
One Reason For Insiders to Buy
Free Email Alerts By Stock:
Start slideshow: